A $5.5 million contract has been awarded by the US Defense Advanced Research Projects Agency (DARPA) to Raytheon to design, fabricate and test self-healing mixed-signal ics.
The HEALICS contract, as it is known, could be worth $11million for Raytheon if both project phases are completed. Phase one involves the demonstration of a self-healing mixed-signal core; and phase two, demonstration of a complete self-healing mixed-signal SoC. This is no small task as DARPA suggests the SoC in question should be in the 100,000 to1million transistor count range and should exhibit self-healing performance, without consuming power more than 5% over the baseline design.
